Afuco™ Anti-Human TNFRSF13C ADCC Therapeutic Antibody (VAY736), ADCC Enhanced
Anti-TNFRSF13C ADCC Enhanced Antibody (VAY736) is an ADCC enhanced antibody produced by our Afuco™ platform. VAY736 is a human immunoglobulin of the G class (IgG1/k) monoclonal antibody (mAb) designed to specifically bind the BAFF receptor. VAY736 can be used for treatment of relapsing-remitting multiple sclerosis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-605CL |
| Pricing | Inquiry |
| Host | Human |
| Target | TNFRSF13C |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, BL, FuncS |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |